Ambani Orgochem Limited (NSE:AMBANIORGO)
India · Delayed Price · Currency is INR 169.75
+8.05 (4.98%)
At close: Oct 16, 2026
Ambani Orgochem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,016 | 2,407 | 1,925 | 1,362 | 1,320 | 1,250 |
Other Revenue | -1.67 | 0 | - | - | 4.46 | 2.69 |
| 3,014 | 2,407 | 1,925 | 1,362 | 1,325 | 1,253 | |
Revenue Growth | 37.04% | 25.03% | 41.36% | 2.81% | 5.77% | 44.34% |
Cost of Revenue | 2,241 | 1,736 | 1,468 | 1,067 | 1,093 | 1,046 |
Gross Profit | 773.09 | 671.37 | 457.55 | 295.47 | 231.57 | 206.23 |
Selling, General & Admin | 119.68 | 97.47 | 81.26 | 83.97 | 42.63 | 42.58 |
Other Operating Expenses | 482.43 | 436.92 | 280.01 | 164.97 | 104.68 | 95.94 |
Operating Expenses | 642.74 | 572.51 | 392.04 | 276.8 | 161.88 | 152.64 |
Operating Income | 130.35 | 98.87 | 65.51 | 18.67 | 69.69 | 53.59 |
Interest Expense | -72.88 | -65.63 | -63.94 | -57.93 | -33.25 | -19.32 |
Interest & Investment Income | 7.51 | 7.51 | 11.47 | 2.37 | 1.96 | 2.08 |
Currency Exchange Gain (Loss) | 20.64 | 20.6 | 0.73 | 1.95 | 0.63 | 5.36 |
Other Non Operating Income (Expenses) | -19.91 | -19.91 | -14.34 | -10.36 | -8.81 | -13.27 |
EBT Excluding Unusual Items | 65.71 | 41.44 | -0.56 | -45.3 | 30.22 | 28.44 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.01 | 0.17 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.67 |
Other Unusual Items | 6.79 | - | 4.88 | 47.29 | -0.46 | - |
Pretax Income | 72.5 | 41.44 | 4.32 | 1.99 | 30.15 | 28.03 |
Income Tax Expense | 26.56 | 28.09 | 12.86 | -28.05 | 10.38 | 7.92 |
Earnings From Continuing Operations | 45.94 | 13.34 | -8.54 | 30.04 | 19.77 | 20.11 |
Minority Interest in Earnings | -0 | - | -0 | - | -0 | -0 |
Net Income | 45.94 | 13.34 | -8.55 | 30.04 | 19.77 | 20.11 |
Preferred Dividends & Other Adjustments | 5.29 | 5.29 | - | - | 6.83 | - |
Net Income to Common | 40.65 | 8.05 | -8.55 | 30.04 | 12.94 | 20.11 |
Net Income Growth | 992.93% | - | - | 132.19% | -35.65% | 18.17% |
Shares Outstanding (Basic) | 8 | 8 | 4 | 9 | 6 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 4 | 9 | 6 | 7 |
Shares Change | 8.36% | 93.48% | -55.68% | 41.95% | -2.09% | 29.37% |
EPS (Basic) | 5.01 | 1.05 | -2.11 | 3.29 | 2.01 | 3.06 |
EPS (Diluted) | 4.93 | 1.03 | -2.11 | 3.29 | 2.01 | 3.06 |
EPS Growth | 908.64% | - | - | 63.58% | -34.27% | -8.66% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -43.17 | -90.29 | -85.95 | -308.37 | -214.75 | -207.26 |
Free Cash Flow Per Share | -5.24 | -11.53 | -21.24 | -33.77 | -33.38 | -31.55 |
Gross Margin | 25.65% | 27.89% | 23.76% | 21.69% | 17.48% | 16.46% |
Operating Margin | 4.32% | 4.11% | 3.40% | 1.37% | 5.26% | 4.28% |
Profit Margin | 1.35% | 0.33% | -0.44% | 2.21% | 0.98% | 1.60% |
Free Cash Flow Margin | -1.43% | -3.75% | -4.46% | -22.64% | -16.21% | -16.55% |
EBITDA | 170.94 | 136.94 | 96.28 | 46.53 | 84.16 | 67.72 |
EBITDA Margin | 5.67% | 5.69% | 5.00% | 3.42% | 6.35% | 5.41% |
D&A For EBITDA | 40.59 | 38.08 | 30.77 | 27.86 | 14.47 | 14.13 |
EBIT | 130.35 | 98.87 | 65.51 | 18.67 | 69.69 | 53.59 |
EBIT Margin | 4.32% | 4.11% | 3.40% | 1.37% | 5.26% | 4.28% |
Effective Tax Rate | 36.63% | 67.80% | 297.96% | - | 34.42% | 28.27% |
Revenue as Reported | 3,043 | 2,437 | 1,939 | 1,367 | 1,328 | 1,260 |
Advertising Expenses | - | 8.8 | 4.32 | 4.74 | 4.37 | 1.67 |